| TwHF group (n = 34) | Valsartan group (n = 31) |
---|---|---|
Any adverse event (n,%) | 13 (38.3) | 12 (38.7) |
Vomiting (n,%) | 1 (2.94) | 0 (0.00) |
Liver dysfunction (n,%) | 3 (8.82) | 0 (0.00) |
Decrease in WBC count (n,%) | 1 (2.94) | 0 (0.00) |
Photosensitive dermatitis (n,%) | 0 (0.00) | 1 (3.22) |
Hyperkalemia (n,%) | 8 (23.53) | 10 (32.2) |
K+ > 6.0 (n,%) | 3 (8.82) | 2 (6.45) |
Doubling of serum creatinine (n,%) | 0 (0.00) | 1 (3.22) |